Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia 16Carcinoma, Renal Cell 15Leukemia, Myeloid, Chronic-Phase 13Kidney Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Melanoma 8Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Hepatocellular 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomach Neoplasms 2Skin Neoplasms 2Recurrence 2Polycythemia Vera 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Methotrexate 21Ifosfamide 21Cyclophosphamide 19Doxorubicin 17Cisplatin 14Filgrastim 13Gemcitabine 12Etoposide 11Leucovorin 9apatinib 8fludarabine 7glucarpidase 6Vincristine 6Temozolomide 6Radiotherapy 6Nivolumab 6Neoadjuvant Therapy 6Drug Therapy 6Carboplatin 6regorafenib 5cabozantinib 5Zoledronic Acid 5Topotecan 5Mesna 5Irinotecan 5Granulocyte Colony-Stimulating Factor 5Docetaxel 5pembrolizumab 4pegfilgrastim 4camrelizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteosarcoma × Interferon-alpha × Clear all
NCT00504140 2012-08-02

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡